What’s Next for SPACs in the Life Sciences Industry? A Discussion with Ginkgo Bioworks


Robert (Bob) H. Cohen will speak on McDermott Will & Emery and BDO’s co-hosted program, “What’s Next for SPACs in the Life Sciences Industry? A Discussion with Ginkgo Bioworks.”

With over 200 special purpose acquisition company (SPAC) IPOs and over 100 SPAC mergers and counting over the last year, SPACs are hotter than ever. But are they the right approach for most Life Sciences companies seeking capital?

Join BDO and McDermott Will & Emery for a discussion with Anna Marie Wagner, Senior Vice President, Corporate Development of Ginkgo Bioworks, around SPACs in the Life Sciences industry.

We’ll discuss:

  • How to evaluate whether a SPAC is the right capital raising vehicle
  • How the new administration has affected the SPAC market
  • Accounting considerations that can potentially derail valuation
  • How to mitigate risks and challenges associated with a SPAC deal

The recording is available here to those with a BDO account.

Dig Deeper

McDermott Event / April 28-29, 2022

Life Sciences Dealmakers Symposium

San Francisco, CA / McDermott Event / January 10-11, 2022

2022 J.P. Morgan Healthcare Conference

Virtual Event / Speaking Engagements / December 1-3, 2021

EIT Health Catapult Awards

Webinar / Speaking Engagements / November 23, 2021

Health & Cybersecurity | Best Practice Post COVID-19

Virtual Conference / Speaking Engagements / November 4, 2021

65th Annual IP Law Conference | Vaccines, IP and Global Equity